- Home
- SHEL vs NVS Comparison
SHEL vs NVS Comparison
Compare SHEL & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SHEL | NVS |
|---|---|---|
| Founded | 1907 | 1895 |
| Country | United Kingdom | Switzerland |
| Employees | 85000 | 75267 |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 258.7B | 278.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SHEL | NVS |
|---|---|---|
| Price | $86.88 | $150.53 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | $93.79 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 7.5M | 1.3M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.25% | 2.16% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $21.75 | $2.30 |
| Revenue Next Year | N/A | $5.27 |
| P/E Ratio | $26.62 | ★ $23.13 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $65.38 | $111.25 |
| 52 Week High | $94.90 | $170.46 |
Technical Indicators
Market Signals| Indicator | SHEL | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 47.65 | 54.36 |
| Support Level | $86.05 | $149.49 |
| Resistance Level | $90.91 | $156.46 |
| Average True Range (ATR) | 1.30 | 1.97 |
| MACD | 0.15 | 0.73 |
| Stochastic Oscillator | 45.88 | 83.17 |
Price Performance
Historical ComparisonAbout SHEL Shell PLC (each representing two (2))
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, it produced 1.5 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At year-end 2024, reserves stood at 9.6 billion barrels of oil equivalent, 48% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with a capacity of 1.6 mmb/d located in the Americas, Asia, and Europe, and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.